Fundraising FoxPuremhc
Austin, US · 1 known investors
Find your way into Puremhc
Sign up to see every warm intro you have to Puremhc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Puremhc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pure MHC discovers HLA Class I and Class II peptide targets for immunotherapies targeting cancer, infectious disease, and autoimmune diseases using the sHLA platform technology.
Founders & leadership
DW
Dr. William HildebrandChief Scientist at Pure MHC and Research Professor in the OU Department of Microbiology and Immunology
Board
TA
Thomas A. HarlanCEO of Emergent Technologies, Inc.
Investors · 1
Frequently asked questions
- What does Puremhc do?
- Pure MHC discovers HLA Class I and Class II peptide targets for immunotherapies targeting cancer, infectious disease, and autoimmune diseases using the sHLA platform technology.
- Who are Puremhc's investors?
- Puremhc's investors include Emergent Technologies, Inc..
- Where is Puremhc headquartered?
- Puremhc is headquartered in Austin, US.